ライフサイエンスコーパス: ear swelling

1 d in draining lymph nodes nor did it prevent ear swelling.

2 oduction, and neutrophil influx and prevents ear swelling.

3 R4KO mice showed a 1.3-fold increase in mean ear swelling, a 2-fold increase in epidermal thickness,

4 Ear swelling after croton oil application was similar in

5 ith MCs protected Sash mice from exacerbated ear swelling after repeated oxazolone challenge.

6 n of MC903 in obese animals led to increased ear swelling and a pronounced Th17-biased inflammatory r

7 king gammadelta T cells) exhibited decreased ear swelling and downregulated expression of IL-22 and I

8 CCR2(-/-) mice had increased ear swelling and epidermal thickening, which was correla

9 mice effectively attenuated P. acnes-induced ear swelling and granulomatous inflammation.

10 use ears, thereby relieving P. acnes-induced ear swelling and granulomatous inflammation.

11 Ear swelling and inflammation persisted for more than 2

12 mice and characterized by significantly less ear swelling and inflammatory cell infiltration than in

13 e antigen challenge significantly suppressed ear swelling and markedly reduced cellular influx.

14 ation effectively decreased contact allergic ear swelling and myeloid immune cell infiltration not on

15 n Bid KO mice and observed markedly enhanced ear swelling and proliferation responses compared with w

16 itivity response, characterized by decreased ear swelling and reduced inflammatory cell infiltrates.

17 antibody to IL-1alpha significantly reduced ear swelling and suppressed the levels of MIP-2, MIP-1al

18 s for in vitro efficacy, and mouse models of ear swelling and systemic anaphylaxis responses for in v

19 ion of PF6-miR-146a nanocomplexes attenuated ear-swelling and reduced the expression of pro-inflammat

20 by a standard chromium release assay and an ear swelling assay, respectively.

21 lloantigens were evaluated by a conventional ear swelling assay.

22 nal expression of beta gal and inhibited the ear-swelling assay for delayed type hypersensitivity.

23 (DTH) responsiveness was assessed using the ear-swelling assay.

24 r hapten challenge but resulted in increased ear swelling at 48 hours and delayed resolution of the i

25 athelicidin demonstrated a large increase in ear swelling, cell infiltration, and MIP-2 expression co

26 Ear swelling chronic contact hypersensitivity responses

27 However, late-phase ear swelling, due to type III hypersensitivity, was sign

28 d correlated with the immune response, i.e., ear swelling, elicited.

29 ment conditions and mouse genotypes measured ear swelling, epidermal thickness, and cytokine expressi

30 ficient (MyD88(-/-)) C57BL/6 mice had intact ear swelling, exaggerated inflammation, and higher level

31 Tolerance was measured from inhibition of ear swelling in a delayed-type hypersensitivity reaction

32 Furthermore, CP-456,773 reduces ear swelling in an imiquimod cream-induced mouse model o

33 After hapten sensitization and re-challenge, ear swelling in CCR6-/- animals was reduced 80% as compa

34 Clinical signs were recorded by ear swelling in mice.

35 adin-specific IgG/IgG2c (in models 1 and 2), ear swelling (in model 1), gluten-dependent enteropathy

36 was orally efficacious in an MMP-12 induced ear-swelling inflammation model in the mouse with a good

37 uces CHS responses, as measured by decreased ear swelling, inhibition of local DETC activation, and a

38 to DNFB in wild-type mice, and DNFB-induced ear swelling is reduced by approximately 50% in TCRdelta

39 yl ester considerably attenuated TPA-induced ear swelling, leukocyte infiltration, epidermal cell pro

40 skin inflammation in both the IL-23-induced ear swelling model and the topical imiquimod model, and

41 nduced mice model and a xylene-induced mouse ear swelling model.

42 utein demonstrated significant inhibition of ear swelling owing to UVB radiation.

43 In wild-type (WT) mice, rmIL-23 induced ear swelling (p < 0.001, all p values versus saline), ep

44 ctions into IL-17A(-/-) mice produced little ear swelling (p < 0.001, versus IL-23-injected WT mice)

45 L-22(-/-) mice resulted in relatively little ear swelling (p < 0.09) and epidermal hyperplasia (p < 0

46 e mice, ODCER transgenic mice showed reduced ear swelling, reduced neutrophil infiltration, and decre

47 The ear swelling response could be prevented by prior infect

48 esponded to DNFB challenge with a pronounced ear swelling response without previous sensitization to

49 expression in basophils was required for the ear swelling response, and basophils promoted the expres

50 deficient DeltadblGATA mice showed only weak ear swelling response, which could be enhanced by eosino

51 urs before antigen challenge but provoked an ear-swelling response directly on application.

52 dingly, Myo9b(-/-) mice showed an attenuated ear-swelling response in a model of contact hypersensiti

53 igh concentrations of anti-IgE Ab induced an ear-swelling response in these strains, implying some ca

54 Ear swelling responses in major histocompatibility compl

55 let-B irradiation showed markedly suppressed ear swelling responses to dinitrofluorobenzene challenge

56 E and Ag-specific IgG1, and generated strong ear-swelling responses to intradermal administration of

57 hase of contact hypersensitivity exacerbated ear-swelling responses.

58 t of the inflammatory response, and examined ear swelling, SK activity, vascular permeability, leukoc

59 BPZE1 nasal pretreatment markedly inhibited ear swelling, skin inflammation, and production of pro-i

60 positive allosteric modulator AEA061 reduced ear swelling, skin thickness, erythema, scale formation,

61 y (CHS) response to oxazolone with increased ear swelling, T-cell infiltration, and expression of Ifn

62 utaneous inflammation was evaluated by mouse ear swelling test (MEST), histology, serum IgE levels, a

63 and tested for immune responsiveness by the ear-swelling test for delayed-type hypersensitivity (DTH

64 Ear swelling was assessed to evaluate the anaphylactic r

65 Also, Il23-induced ear swelling was diminished in Trex2 knockout mice in co

66 Impaired skin eosinophilia and reduced ear swelling was further observed in IL-4/IL-13-deficien

67 In accordance, DNFB-induced ear swelling was reduced by approximately 50% in IL-17(-